INSILICO (03696) has been included in the Hang Seng Composite Index constituents.

date
08:03 20/02/2026
avatar
GMT Eight
Innovent Biologics (03696) announced that the company has been selected by Hang Seng Indexes Company Limited and will be included in the Hang Seng Composite Index, effective from March 9, 2026.
INSILICO (03696) announced that the company has been selected by Hang Seng Indexes Company Limited and will be included in the Hang Seng Composite Index as of March 9, 2026. After being included in the Hang Seng Composite Index, the company's shares are expected to meet the inclusion criteria for trading under the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect. The Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect are channels for stock trading and investment between mainland China and Hong Kong capital markets. The board of directors believes that being included in the Hang Seng Composite Index reflects the high recognition of the company's industry position, business performance, and value by the international capital markets. This move is expected to further enhance the liquidity of the company's stock, expand the investor base through a diversified shareholder structure, and promote the company's long-term development.